{
    "2018-03-20": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Novartis Sales Reps Will Testify About Lavish Meals, U.S. Says",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Sales",
                        "Reps",
                        "Testify",
                        "Lavish",
                        "Meals",
                        "U.S."
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Swiss Stock Market Recovered Some Lost Ground",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock",
                        "Market",
                        "Recovered",
                        "Lost",
                        "Ground"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis Partners With Harvard To Develop Biomaterial Systems",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Partners",
                        "Harvard",
                        "Develop",
                        "Biomaterial",
                        "Systems"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}